IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.
- DOI
- 10.1007/s12013-026-02161-6
- Published
- 2026 Sep 18
- Container
- Cell biochemistry and biophysics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12013-026-02161-6,
title = {IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.},
author = {Jia W and Wang H and Zhang L and Yang L and Yu J and Yang J and Geng C},
year = {2026},
journal = {Cell biochemistry and biophysics},
doi = {10.1007/s12013-026-02161-6},
url = {https://doi.org/10.1007/s12013-026-02161-6}
}RIS
TY - JOUR TI - IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab. AU - Jia W AU - Wang H AU - Zhang L AU - Yang L AU - Yu J AU - Yang J AU - Geng C PY - 2026 JO - Cell biochemistry and biophysics DO - 10.1007/s12013-026-02161-6 UR - https://doi.org/10.1007/s12013-026-02161-6 ER -
APA
W, J., H, W., L, Z., L, Y., J, Y., J, Y., & C, G. (2026). IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.. Cell biochemistry and biophysics. https://doi.org/10.1007/s12013-026-02161-6
Source records
- pubmed · retrieved 2026-09-25T22:45:03.782Z